 2. One or more standard deviations below the mean on the Attention or Working Memory Indices of the WRAML 2 56 or Attention or Working Memory Indices that are one or more standard deviations below the participants estimated IQ. These criteria are similar to those used in a trial of methylphenidate with survivors of childhood cancer. 